Citadel Advisors’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.46M | Sell |
84,173
-558,589
| -87% | -$10.6M | ﹤0.01% | 6773 |
|
|
2025
Q4 | $12.1M | Buy |
642,762
+18,949
| +3% | +$317K | ﹤0.01% | 3003 |
|
|
2025
Q3 | $9.07M | Sell |
623,813
-166,854
| -21% | -$2.38M | ﹤0.01% | 3418 |
|
|
2025
Q2 | $15.4M | Sell |
790,667
-3,145
| -0.4% | -$55.9K | ﹤0.01% | 2461 |
|
|
2025
Q1 | $14.1M | Buy |
793,812
+283,768
| +56% | +$6.11M | ﹤0.01% | 2436 |
|
|
2024
Q4 | $10.9M | Buy |
510,044
+98,357
| +24% | +$2.39M | ﹤0.01% | 2876 |
|
|
2024
Q3 | $12.9M | Buy |
411,687
+291,186
| +242% | +$7.25M | ﹤0.01% | 2559 |
|
|
2024
Q2 | $1.87M | Buy |
120,501
+40,440
| +51% | +$489K | ﹤0.01% | 5442 |
|
|
2024
Q1 | $848K | Sell |
80,061
-76,885
| -49% | -$769K | ﹤0.01% | 7282 |
|
|
2023
Q4 | $1.88M | Sell |
156,946
-36,779
| -19% | -$301K | ﹤0.01% | 5465 |
|
|
2023
Q3 | $1.36M | Buy |
193,725
+74,588
| +63% | +$689K | ﹤0.01% | 5967 |
|
|
2023
Q2 | $1.01M | Sell |
119,137
-308,729
| -72% | -$2.57M | ﹤0.01% | 6431 |
|
|
2023
Q1 | $3.91M | Buy |
427,866
+202,594
| +90% | +$2.59M | ﹤0.01% | 4204 |
|
|
2022
Q4 | $2.57M | Sell |
225,272
-226,589
| -50% | -$3.36M | ﹤0.01% | 5016 |
|
|
2022
Q3 | $7.69M | Buy |
451,861
+209,979
| +87% | +$4.51M | ﹤0.01% | 3149 |
|
|
2022
Q2 | $5.2M | Buy |
241,882
+48,514
| +25% | +$1.35M | ﹤0.01% | 3719 |
|
|
2022
Q1 | $7.15M | Buy |
193,368
+10,270
| +6% | +$400K | ﹤0.01% | 3513 |
|
|
2021
Q4 | $8.33M | Sell |
183,098
-206,024
| -53% | -$10.8M | ﹤0.01% | 3365 |
|
|
2021
Q3 | $24.7M | Buy |
389,122
+341,204
| +712% | +$26M | 0.01% | 1769 |
|
|
2021
Q2 | $4.39M | Sell |
47,918
-28,187
| -37% | -$2.24M | ﹤0.01% | 4721 |
|
|
2021
Q1 | $5.18M | Buy |
76,105
+51,326
| +207% | +$3.99M | ﹤0.01% | 4177 |
|
|
2020
Q4 | $1.79M | Sell |
24,779
-31,258
| -56% | -$1.81M | ﹤0.01% | 5562 |
|
|
2020
Q3 | $2.13M | Buy |
+56,037
| New | +$1.89M | ﹤0.01% | 4607 |
|
|
2020
Q2 | – | Sell |
-79,735
| Closed | -$2.27M | – | 9820 |
|
|
2020
Q1 | $1.74M | Buy |
79,735
+902
| +1% | +$20.2K | ﹤0.01% | 4375 |
|
|
2019
Q4 | $1.7M | Sell |
78,833
-76,116
| -49% | -$1.75M | ﹤0.01% | 4685 |
|
|
2019
Q3 | $3.5M | Buy |
154,949
+142,918
| +1,188% | +$3.96M | ﹤0.01% | 3610 |
|
|
2019
Q2 | $433K | Sell |
12,031
-55,602
| -82% | -$1.78M | ﹤0.01% | 7042 |
|
|
2019
Q1 | $2.13M | Buy |
+67,633
| New | +$1.97M | ﹤0.01% | 4358 |
|
|
2018
Q3 | – | Sell |
-26,216
| Closed | -$321K | – | 9230 |
|
|
2018
Q2 | $321K | Buy |
26,216
+7,156
| +38% | +$82.1K | ﹤0.01% | 7097 |
|
|
2018
Q1 | $152K | Buy |
+19,060
| New | +$117K | ﹤0.01% | 7528 |
|
Other funds holding CDNA
AIM
DM
B
VCM
GS
Citadel Advisors's CDNA Position: Q1 2026 in Review
Citadel Advisors reduced its CareDx (CDNA) stake by 87% in Q1 2026, selling an estimated $10.6M and leaving 84,173 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #6773.
Citadel Advisors first reported a position in CDNA in Q1 2018 and has held it in 30 quarters since. The position peaked at $24.7M in Q3 2021. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.
- Citadel Advisors held 84,173 shares of CareDx worth $1.46M as of Q1 2026.
- Citadel Advisors sold 558,589 CareDx shares in Q1 2026, an estimated $10.6M.
- CareDx made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6773 holding.
- Citadel Advisors first reported a position in CareDx in Q1 2018 and has held it in 30 quarters since.
- Citadel Advisors's CareDx position peaked at $24.7M in Q3 2021.
- 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.